
A study found that children with multisystem inflammatory syndrome (MIS-C), a rare condition linked to COVID-19, have distinct biochemical indicators of cell injury and cell death compared to other children with COVID-19. By analyzing blood samples from 237 patients, researchers could distinguish between patients with MIS-C and COVID-19, which could lead to the development of tests that allow clinicians to distinguish between MIS-C and other conditions involving widespread inflammation.
Like
Save
Share